Enable job alerts via email!
Boost your interview chances
Create a job specific, tailored resume for higher success rate.
A leading pharmaceutical company seeks a Senior Scientist II to develop and optimize cell-based assays for high-throughput functional genomic screening in Cambridge, MA. The ideal candidate will possess strong expertise in functional genomics, advanced cell models, and has a PhD with relevant experience. This role offers competitive compensation, including a performance-based cash incentive and comprehensive benefits.
Job ID REQ-10054504
USA
We are currently seeking individuals with strong expertise in functional genomics and molecular biology. The ideal candidate will have substantial experience in genomic screening, complex cell models and automation. You will be responsible for developing and optimizing cell-based assays specifically for high-throughput functional genomic screening, with the goal of identifying targets and accelerating therapeutic development.
Internal Job Title: Senior Scientist II
Position Location: Cambridge, MA, onsite
We are currently seeking individuals with strong expertise in functional genomics and iPSC-based disease modeling. The ideal candidate will have substantial experience in genomic screening and complex cell models. You will be responsible for developing and optimizing cell-based assays specifically for high-throughput functional genomic screening, with the goal of identifying targets and accelerating therapeutic development.
Your responsibilities include, but are not limited to:
The salary for this position is expected to range between $93,800 and $174,200 per year.
The final salary offered is determined based on factors like, but not limited to, relevant skills and experience, and upon joining Novartis will be reviewed periodically. Novartis may change the published salary range based on company and market factors.
Your compensation will include a performance-based cash incentive and, depending on the level of the role, eligibility to be considered for annual equity awards.
US-based eligible employees will receive a comprehensive benefits package that includes health, life and disability benefits, a 401(k) with company contribution and match, and a variety of other benefits. In addition, employees are eligible for a generous time off package including vacation, personal days, holidays and other leaves.
Why Novartis: Helping people with disease and their families takes more than innovative science. It takes a community of smart, passionate people like you. Collaborating, supporting and inspiring each other. Combining to achieve breakthroughs that change patients’ lives. Ready to create a brighter future together? https://www.novartis.com/about/strategy/people-and-culture
Join our Novartis Network: Not the right Novartis role for you? Sign up to our talent community to stay connected and learn about suitable career opportunities as soon as they come up: https://talentnetwork.novartis.com/network
The Novartis Group of Companies are Equal Opportunity Employers. We do not discriminate in recruitment, hiring, training, promotion or other employment practices for reasons of race, color, religion, sex, national origin, age, sexual orientation, gender identity or expression, marital or veteran status, disability, or any other legally protected status.
Accessibility & Reasonable Accommodations
The Novartis Group of Companies are committed to working with and providing reasonable accommodation to individuals with disabilities. If, because of a medical condition or disability, you need a reasonable accommodation for any part of the application process, or to perform the essential functions of a position, please send an e-mail to us.reasonableaccommodations@novartis.com or call +1(877)395-2339 and let us know the nature of your request and your contact information. Please include the job requisition number in your message.
Division Biomedical Research
Business Unit Pharma Research
Location USA
State Massachusetts
Site Cambridge (USA)
Company / Legal Entity U175 (FCRS = US175) Novartis Institutes for BioMedical Research, Inc.